Pancreatic endocrine neoplasms: a current update on genetics and imaging.

Pancreatic endocrine neoplasms are rare pancreatic tumours that may occur sporadically or as part of inherited syndromes such as multiple endocrine neoplasia-1 syndrome, von Recklinghausen disease, von Hippel-Lindau syndrome and tuberous sclerosis complex. Recent advances in the genetics and pathology of hereditary syndromes have provided valuable insights into the pathophysiology and biology of sporadic pancreatic endocrine neoplasms. Evolving molecular data on the biology of these neoplasms have the potential for diagnostic, therapeutic and prognostic use.

[1]  C. Fletcher,et al.  Diagnostic histopathology of tumors , 2013 .

[2]  Nuria Peris Tomás,et al.  [Pancreatic involvement in Von Hippel-Lindau disease]. , 2013, Gastroenterologia y hepatologia.

[3]  雅州 坂口,et al.  [Von Hippel-Lindau disease]. , 2012 .

[4]  R. Thakker,et al.  Multiple endocrine neoplasia type 1. , 1999, Endocrine-related cancer.

[5]  A. Andrén-sandberg.  Pancreatic endocrine tumors , 2011, North American journal of medical sciences.

[6]  M. Giovannini.  Contrast-enhanced and 3-dimensional endoscopic ultrasonography. , 2010, Gastroenterology clinics of North America.

[7]  B. Eriksson.  New drugs in neuroendocrine tumors: rising of new therapeutic philosophies? , 2010, Current opinion in oncology.

[8]  Z. Sparchez,et al.  Contrast-enhanced ultrasound of the pancreas--a method beyond its potential or a new diagnostic standard? , 2009, Journal of gastrointestinal and liver diseases : JGLD.

[9]  J. Norton,et al.  Endocrine Neoplasms of the Pancreas , 2009 .

[10]  G. Procopio,et al.  Activity of sunitinib in patients with advanced neuroendocrine tumors. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  D. Metz,et al.  Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors. , 2008, Gastroenterology.

[12]  D. Bingham,et al.  Inherited pancreatic endocrine tumor syndromes: Advances in molecular pathogenesis, diagnosis, management, and controversies , 2008, Cancer.

[13]  S. Baldus,et al.  High Expression of Heparanase is Significantly Associated with Dedifferentiation and Lymph Node Metastasis in Patients with Pancreatic Ductal Adenocarcinomas and Correlated to PDGFA and Via HIF1a to HB-EGF and bFGF , 2008, Journal of Gastrointestinal Surgery.

[14]  D. Sahani,et al.  Cystic pancreatic endocrine neoplasms: a distinct tumor type? , 2008, Journal of the American College of Surgeons.

[15]  C. Rubio,et al.  Somatostatinoma: Clinico‐pathological features of three cases and literature reviewed , 2008, Journal of gastroenterology and hepatology.

[16]  R. Jensen,et al.  Gastroenteropancreatic neuroendocrine tumours. , 2008, The Lancet. Oncology.

[17]  A. Moser,et al.  EUS-guided FNA diagnosis of pancreatic endocrine tumors: new trends identified. , 2008, Gastrointestinal endoscopy.

[18]  Laura H. Tang,et al.  Determining prognosis in patients with pancreatic endocrine neoplasms: can the WHO classification system be simplified? , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  R. Salazar,et al.  New drug development in digestive neuroendocrine tumors. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

[20]  M. Kulke,et al.  Emerging therapies for the treatment of patients with advanced neuroendocrine tumors , 2007, Expert opinion on emerging drugs.

[21]  James C Yao,et al.  Neuroendocrine tumors. Molecular targeted therapy for carcinoid and islet-cell carcinoma. , 2007, Best practice & research. Clinical endocrinology & metabolism.

[22]  L. Kvols,et al.  A review of the current clinical trials for gastroenteropancreatic neuroendocrine tumours , 2007, Expert opinion on investigational drugs.

[23]  F. Miller,et al.  MRI of islet cell tumors of the pancreas. , 2006, AJR. American journal of roentgenology.

[24]  Kentaro Takahashi,et al.  [Von Hippel-Lindau disease]. , 2006, Nihon rinsho. Japanese journal of clinical medicine.

[25]  AB Trovó‐Marqui,et al.  Neurofibromin: a general outlook , 2006, Clinical genetics.

[26]  F. Meric-Bernstam,et al.  Phase II study of RAD001 (everolimus) and depot octreotide (Sandostatin LAR) in patients with advanced low grade neuroendocrine carcinoma (LGNET). , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  E. Maher,et al.  Von Hippel-Lindau disease and endocrine tumour susceptibility. , 2006, Endocrine-related cancer.

[28]  W. Knoefel,et al.  Microadenomatosis of the Endocrine Pancreas in Patients With and Without the Multiple Endocrine Neoplasia Type 1 Syndrome , 2006, The American journal of surgical pathology.

[29]  A. Bardia,et al.  Hand-foot syndrome after dose-dense adjuvant chemotherapy for breast cancer: a case series. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  G. Åkerström,et al.  Pancreatic tumours as part of the MEN-1 syndrome. , 2005, Best practice & research. Clinical gastroenterology.

[31]  C. Bordi,et al.  Aetiology, molecular pathogenesis and genetics , 2005 .

[32]  W. Simonds,et al.  Hereditary hormone excess: genes, molecular pathways, and syndromes. , 2005, Endocrine reviews.

[33]  C. Johannessen,et al.  The NF1 tumor suppressor critically regulates TSC2 and mTOR. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[34]  R. Lloyd,et al.  Preliminary results of a phase II trial of gefitinib in progressive metastatic neuroendocrine tumors (NET): A Phase II Consortium (P2C) study , 2005 .

[35]  Y. Morioka,et al.  Clinical pathology of endocrine tumors of the pancreas , 1991, Digestive Diseases and Sciences.

[36]  C. Bordi,et al.  Endocrine tumours of the gastrointestinal tract: aetiology, molecular pathogenesis and genetics. , 2005, Best practice & research. Clinical gastroenterology.

[37]  B. Sipos,et al.  [Tumors of the endocrine pancreas]. , 2005, Der Pathologe.

[38]  A. Knudson.  Hereditary cancer: Two hits revisited , 2005, Journal of Cancer Research and Clinical Oncology.

[39]  J. Neoptolemos,et al.  Hereditary Pancreatic Endocrine Tumours , 2004, Pancreatology.

[40]  A. McLean,et al.  Endoscopic ultrasound in the detection of pancreatic islet cell tumours , 2004, Cancer imaging : the official publication of the International Cancer Imaging Society.

[41]  G. Bommer,et al.  Pancreatic glucagonoma with and without syndrome , 1980, Virchows Archiv A.

[42]  M. Falconi,et al.  Neuroendocrine pancreatic tumor: value of contrast enhanced ultrasonography. , 2004, Abdominal imaging.

[43]  R. DeLellis.  Pathology and genetics of tumours of endocrine organs , 2004 .

[44]  G. Klöppel.  [Tumors of the endocrine pancreas]. , 2005, Der Pathologe.

[45]  R. Boldrini,et al.  Malignant Pancreatic Endocrine Tumor in a Child With Tuberous Sclerosis , 2003, The American journal of surgical pathology.

[46]  H. Gouya,et al.  CT, endoscopic sonography, and a combined protocol for preoperative evaluation of pancreatic insulinomas. , 2003, AJR. American journal of roentgenology.

[47]  J. Fletcher,et al.  Preoperative detection of pancreatic insulinomas on multiphasic helical CT. , 2003, AJR. American journal of roentgenology.

[48]  B. Teh.  Multiple endocrine neoplasia , 2003, Journal of internal medicine.

[49]  W. Frankel,et al.  Neuroendocrine Carcinomas of the Pancreas With `Rhabdoid' Features , 2003, The American journal of surgical pathology.

[50]  M. Fjällskog,et al.  Expression of molecular targets for tyrosine kinase receptor antagonists in malignant endocrine pancreatic tumors. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[51]  S. Rickes,et al.  Differentiation of Neuroendocrine Tumors from Other Pancreatic Lesions by Echo-Enhanced Power Doppler Sonography and Somatostatin Receptor Scintigraphy , 2003, Pancreas.

[52]  E. Fishman,et al.  Helical CT of islet cell tumors of the pancreas: typical and atypical manifestations. , 2002, AJR. American journal of roentgenology.

[53]  R. Reznek,et al.  Imaging pancreatic islet cell tumours , 2002 .

[54]  S. Curley,et al.  High frequency loss of heterozygosity in von Hippel-Lindau (VHL)-associated and sporadic pancreatic islet cell tumors: evidence for a stepwise mechanism for malignant conversion in VHL tumorigenesis. , 2002, Cancer research.

[55]  M. Eledrisi,et al.  Insulinoma in a patient with tuberous sclerosis: is there an association? , 2002, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[56]  E. Berg,et al.  World Health Organization Classification of Tumours , 2002 .

[57]  A. Scarpa,et al.  Role of disease‐causing genes in sporadic pancreatic endocrine tumors: MEN1 andVHL , 2001, Genes, chromosomes & cancer.

[58]  G. Åkerström,et al.  Multiple allelic deletions and intratumoral genetic heterogeneity in men1 pancreatic tumors. , 2001, The Journal of clinical endocrinology and metabolism.

[59]  O. Iliopoulos.  von Hippel-Lindau disease: genetic and clinical observations. , 2001, Frontiers of hormone research.

[60]  S. Libutti,et al.  Clinical and genetic analysis of patients with pancreatic neuroendocrine tumors associated with von Hippel-Lindau disease. , 2000, Surgery.

[61]  S. Richard,et al.  Pancreatic involvement in von Hippel–Lindau disease , 2000 .

[62]  T. Ichikawa,et al.  Islet cell tumor of the pancreas: biphasic CT versus MR imaging in tumor detection. , 2000, Radiology.

[63]  B. Wiedenmann,et al.  Endoscopic Ultrasonography of Neuroendocrine Tumours , 2000, Digestion.

[64]  R. Semelka,et al.  Neuroendocrine tumors of the pancreas: Spectrum of appearances on MRI , 2000, Journal of magnetic resonance imaging : JMRI.

[65]  R. Jensen,et al.  Genotype/phenotype correlation of multiple endocrine neoplasia type 1 gene mutations in sporadic gastrinomas. , 2000, The Journal of clinical endocrinology and metabolism.

[66]  S. Richard,et al.  Pancreatic involvement in von Hippel-Lindau disease. The Groupe Francophone d'Etude de la Maladie de von Hippel-Lindau. , 2000, Gastroenterology.

[67]  H. Höfler,et al.  Loss of heterozygosity in 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[68]  R. Jensen,et al.  Pancreatic endocrine tumors: recent advances. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[69]  S. Libutti,et al.  Multiple neuroendocrine tumors of the pancreas in von Hippel-Lindau disease patients: histopathological and molecular genetic analysis. , 1998, The American journal of pathology.

[70]  R. Snell,et al.  Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products. , 1998, Human molecular genetics.

[71]  F. Collins,et al.  Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas. , 1997, Cancer research.

[72]  D. Chung,et al.  A novel pancreatic endocrine tumor suppressor gene locus on chromosome 3p with clinical prognostic implications. , 1997, The Journal of clinical investigation.

[73]  B. Korf,et al.  The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. , 1997, JAMA.

[74]  C. Larsson,et al.  Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1. , 1997, Human molecular genetics.

[75]  J. Doppman,et al.  Growth of newly diagnosed, untreated metastatic gastrinomas and predictors of growth patterns. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[76]  F. Collins,et al.  Haplotype analysis defines a minimal interval for the multiple endocrine neoplasia type 1 (MEN1) gene. , 1997, Cancer research.

[77]  L. V. Van Hoe,et al.  Helical CT for the preoperative localization of islet cell tumors of the pancreas: value of arterial and parenchymal phase images. , 1995, AJR. American journal of roentgenology.

[78]  A. Dachman,et al.  Islet cell tumors of the pancreas: pathologic-imaging correlation among size, necrosis and cysts, calcification, malignant behavior, and functional status. , 1995, AJR. American journal of roentgenology.

[79]  A. Warshaw,et al.  Cystic tumors of the pancreas. , 1995, The Surgical clinics of North America.

[80]  A. Vinik,et al.  Clinical review 72: diagnosis and management of functioning islet cell tumors. , 1995, The Journal of clinical endocrinology and metabolism.

[81]  J. Howard,et al.  Von recklinghausen's disease associated with duodenal somatostatinoma: Contrast of duodenal versus pancreatic somatostatinomas , 1995, Journal of surgical oncology.

[82]  R. Jensen,et al.  Endocrine tumors of the pancreas : recent advances in research and management , 1995 .

[83]  G. Klöppel,et al.  Histopathology and Immunopathology of Pancreatic Endocrine Tumors , 1994 .

[84]  R. Semelka,et al.  Islet cell tumors: comparison of dynamic contrast-enhanced CT and MR imaging with dynamic gadolinium enhancement and fat suppression. , 1993, Radiology.

[85]  H. Brambs,et al.  Pancreatic lesions in the von Hippel-Lindau syndrome. , 1991, Gastroenterology.

[86]  D. Ballard,et al.  Functioning insulinoma--incidence, recurrence, and long-term survival of patients: a 60-year study. , 1991, Mayo Clinic proceedings.

[87]  M. Zinner,et al.  Anatomic distribution of pancreatic endocrine tumors. , 1990, American journal of surgery.

[88]  D. Henson,et al.  Cystic tumors of the pancreas. , 1990, Pathology annual.

[89]  D. Allison,et al.  Endocrine tumors of the pancreas. , 1989, Radiologic clinics of North America.

[90]  J. Norton,et al.  Prospective Study of Gastrinoma Localization and Resection in Patients with Zollinger‐Ellison Syndrome , 1986, Annals of surgery.

[91]  P. Sheedy,et al.  CT features of nonfunctioning islet cell carcinoma. , 1984, AJR. American journal of roentgenology.

[92]  T. Warner,et al.  Immunohistochemical detection of chromogranin and neuron‐specific enolase in pancreatic endocrine neoplasms , 1984, The American journal of surgical pathology.

[93]  R. Prinz,et al.  Clinical aspects of glucagon-producing islet cell tumors. , 1981, The American journal of gastroenterology.

[94]  H. Imhof,et al.  Pancreatic calcifications in malignant islet cell tumors. , 1977, Radiology.